Our study demonstrated a highly significant reduction in spleen and liver size during the study period as reflected by a significant decline in serum ferritin levels and blood transfusions.
← all excerpts
Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study.
1
—
—